Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Exec Compensation
confidence 92%
filed 2026-08-25
EX-99.1
This exhibit is the CCH Holdings Ltd 2026 Second Equity Incentive Plan, a comprehensive equity compensation plan document that establishes the framework for granting stock options, restricted stock, restricted stock units, and other equity awards to directors, officers, employees, and consultants. The plan's stated purpose is to "attract and retain key personnel" and allow participants to "acquire and maintain an equity interest in the Company." This is a material disclosure of compensatory arrangements for executives and other eligible persons, falling squarely within the exec_compensation category.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 92%
filed 2026-08-25
The 6-K discloses that Masonglory has regained compliance with Nasdaq's minimum bid price requirement (Listing Rule 5550(a)(2)) after receiving a non-compliance notice on March 13, 2026. While the current filing announces resolution of the delisting risk through a share consolidation that restored the stock price above $1.00, the underlying event—the company's prior failure to maintain minimum listing standards and the associated delisting threat—is material to investors' assessment of the registrant's listing status and financial condition.
View raw filing on EDGAR →
8-K
Terminal Other
confidence 90%
filed 2026-08-25
Item 2.01
The Board unanimously approved a deleveraging plan and committed to the Company's likely full liquidation and dissolution. The Company completed the sale of 75.8% of its investment portfolio (~$73 million in gross proceeds), with approximately $65 million to be used to pay off the credit facility in full, and plans to seek shareholder approval for full liquidation and wind-down by year-end.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-08-25
EX-99.1
This exhibit discloses regulatory correspondence and Holcim's response regarding the acquisition of 99.99% of Inversiones ASPI S.A. (which holds 50.01% of CPAC) by Holcim Ltd. The filing clarifies the purchase price mechanics—an Enterprise Value of USD 1.5 billion adjusted to an Equity Value of S/ 3.7 billion (S/ 1,850,370,000 for the 50.01% stake), with final deductions of S/ 210,042,776 for debt payoff and excess transaction expenses, resulting in a Final Purchase Price of S/ 1,640,327,224. This is a material acquisition/change of control event that would significantly affect investor assessment of the registrant's ownership and valuation.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 96%
filed 2026-08-25
Item 3.01
Maison Solutions received a notification letter from Nasdaq on August 20, 2026, stating that the Company failed to timely file its Form 10-K for fiscal year ended April 30, 2026, and therefore no longer satisfies Nasdaq Listing Rule 5250(c)(1). The Company has 60 days to submit a compliance plan or face potential delisting.
View raw filing on EDGAR →
6-K
Financial Other
confidence 75%
filed 2026-08-25
EX-99.1
BW LPG announces the sale of the vessel BW Birch by its 52%-owned subsidiary BW LPG India, generating approximately US$37 million net book gain and US$64 million net cash proceeds. This is a material asset disposition and capital event, but does not fit the specific `ma_activity` category (which typically covers acquisitions, mergers, or changes of control) nor the `debt_issuance` or `dividend_distribution` categories. The sale is a significant financial transaction affecting the company's asset base and cash position, making it a material financial event best classified as `financial_other`.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-25
Item 2.02
Vyome Holdings issued a press release on August 25, 2026 announcing financial results for the second fiscal quarter ended June 30, 2026, disclosing cash position ($7.9M), operating expenses ($874K), and net loss ($720K per share). The filing includes summary consolidated balance sheets and statements of operations, which are typical of an earnings release disclosure under Item 2.02.
View raw filing on EDGAR →
6-K
Exec departure
confidence 95%
filed 2026-08-25
Mr. Ziqian Guan, a director of Scage Future, resigned from his position effective August 21, 2026, due to personal reasons with no disagreement with the Company. Director departures are material governance events that affect the composition and oversight structure of the board, and would be relevant to a reasonable investor's assessment of the registrant.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-08-25
Item 7.01
This Item 7.01 disclosure updates an investor presentation related to a proposed public offering (S-1 registration statement, Registration No. 333-297558) with a price range of $4.00–$5.00 per share and up to $15 million in gross proceeds. While the presentation itself is a routine Regulation FD disclosure, the underlying event—a material equity offering by a small-cap company transitioning from OTCQB to Nasdaq Capital Market—is material to investors. However, the disclosure does not fit neatly into the taxonomy: it is neither a completed M&A transaction (ma_activity), a dilutive issuance of unregistered securities (dilutive_issuance), nor a traditional earnings release. The offering is still pending SEC effectiveness and Nasdaq approval, making it a forward-looking capital event rather than a consummated transaction. Classified as other_material because the domain is financial/capital-raising but the specific event type (a proposed registered offering) does not align with the defined categories.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-08-25
Item 8.01
Adaptin Bio announced the opening of enrollment in a Phase 1 clinical trial for APTN-101, its proprietary BRiTE therapeutic for glioblastoma treatment. This represents a material operational and clinical development milestone—the transition from preclinical to first-in-human clinical testing—that would affect a reasonable investor's assessment of the company's pipeline progress and near-term value drivers. While not fitting a specific named event type, this is clearly an operational/strategic milestone in the company's drug development program.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-08-25
The 6-K discloses results of an extraordinary general meeting held on August 24, 2026, where shareholders voted on seven material proposals including amendment of authorized shares, change of voting power for Class B shares, share consolidation authorization, and redomiciliation from the British Virgin Islands to the Cayman Islands. Each proposal shows voting tallies (For/Against/Abstain) and approval status, directly matching the shareholder_vote_results taxonomy.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-08-25
Item 2.01
reAlpha Tech Corp. completed its acquisition of InstaMortgage on August 19, 2026, pursuant to the A&R Merger Agreement, with merger consideration totaling $8.5 million in cash, stock, and deferred payments. The acquisition was completed prior to obtaining required state regulatory approvals in two states representing approximately 21–23% of InstaMortgage's loan origination volume, creating material regulatory risk including potential fines, penalties, and operational restrictions.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 85%
filed 2026-08-25
The 6-K announces the results of an Extraordinary General Meeting held on August 21, 2026, where shareholders approved a 1-for-40 share consolidation. The filing discloses the shareholder vote outcome and the marketplace effective date (September 8, 2026) for implementation. While the primary action is a capital structure change, the filing's core disclosure is the shareholder vote approval and its effective date, which is material to investors as it affects share count and trading mechanics.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-25
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting held on August 25, 2026, filed under Item 5.07. The filing reports the outcomes of four proposals: election of two Class I Directors (both approved), ratification of the independent auditor (approved), an amendment to increase authorized shares (not approved), and a withdrawn adjournment proposal. The failure to approve the share authorization increase is material to investors assessing the company's capital structure flexibility.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-25
The filing discloses the appointment of Dr. Mukesh Prasad as a director and member of the audit and compensation committees of Cantor Equity Partners IV, Inc., effective August 25, 2026. Item 5.02(d) explicitly covers "Appointment of Certain Officers" and the prose centers on Dr. Prasad taking a board role with committee assignments. Board appointments are material governance events affecting investor assessment of the company's leadership and oversight structure.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-08-25
Item 3.02
The filing discloses a material inducement stock option grant of 307,814 shares to an individual becoming an employee, approved by the Compensation Committee and issued under Nasdaq Rule 5635(c)(4). While Item 3.02 typically covers dilutive equity issuances, the substance here is an executive compensation arrangement—a stock option award with vesting conditions tied to continued service. This is a compensatory arrangement for a named executive or officer, making exec_compensation the most precise classification, though the Item 3.02 designation and unregistered securities language create some ambiguity.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-25
Item 5.07
This Item 5.07 discloses the final results of a Special Meeting of Stockholders held on August 25, 2026, with voting outcomes on four proposals: approval of issuance of shares to Mandragola Ltd. in connection with an acquisition of Dr. Frucht Systems Ltd., approval of a reverse stock split (1-for-5 to 1-for-20), ratification of Barzily & Co. as independent auditor, and an adjournment proposal. All three substantive proposals passed with strong majorities. The disclosure includes vote counts, abstentions, and broker non-votes as required by Item 5.07, making this a clear shareholder vote results disclosure that is material to investors assessing the company's capital structure and governance decisions.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-08-25
Item 3.01
BioRestorative Therapies received a delinquency notification from Nasdaq on August 21, 2026, for failure to timely file its Form 10-Q, placing the company in non-compliance with Nasdaq Listing Rule 5250(c)(1). The company has until October 20, 2026, to submit a compliance plan and until February 16, 2027, to regain compliance, with explicit risk of delisting if it fails to do so. This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →
6-K
Governance Other
confidence 80%
filed 2026-08-25
EX-99.2
Yueda Digital is soliciting shareholder approval for a 1-for-10 share consolidation affecting both Class A and Class B ordinary shares and an amendment and restatement of the company's memorandum and articles of association to reflect the consolidation. The extraordinary general meeting is scheduled for September 14, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-08-25
Item 5.02
The filing discloses both the voluntary resignation of CEO Miles Suk (effective August 19, 2026) and the appointment of M. Fatih Karatas as Interim CEO (effective August 25, 2026). While both events are disclosed, the principal action emphasized is the appointment of a new interim CEO with detailed background and qualifications, making exec_appointment the most salient classification. The departure is secondary context to the leadership transition.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-25
EX-99.1
This news release discloses results of advanced metallurgical test work on the Apollo deposit showing strong recovery rates (95% gold, 92% silver, 85% copper, 70% tungsten) and announces acceleration of the timeline to release a maiden mineral resource estimate in September 2026. The disclosure is primarily operational—reporting on exploration and development progress at the flagship Guayabales Project—rather than a discrete event like M&A, executive change, or financial results. It is material because metallurgical recovery rates and resource estimation timelines directly affect investor assessment of the project's development potential and value.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-08-25
EX-99.1
Sun Life and Wilton Re have entered into a definitive agreement to establish a strategic reinsurance and asset management partnership involving the creation of Windsor Life Re, a new reinsurer capitalized with approximately US$900 million (with Sun Life and Wilton Re each contributing roughly one-third of equity), and an initial in-force block reinsurance of approximately US$1.7 billion. This constitutes a material acquisition/partnership transaction that combines significant capital deployment, asset management responsibilities, and business integration, expected to launch in H1 2027 subject to regulatory approvals.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-25
Item 1.01
Grown Rogue entered into a series of definitive agreements on August 20–21, 2026, to facilitate its planned acquisition of PharmaCann Inc.'s New York license and assets (PCNY), including cultivation facilities and four dispensaries, with an anticipated purchase price of approximately $4.5 million. The transaction involves formation of a joint venture (GRNY, 51% Grown Rogue / 49% capital partner), $15 million in committed project-based financing, and interim operating agreements to preserve and transition the business pending finalization of definitive purchase agreements within four weeks.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-25
Item 3.02
Grown Rogue issued unregistered equity securities to a capital partner in connection with the PharmaCann acquisition financing, including 300,000 subordinate voting shares as a commitment fee, warrants exercisable at $0.55, and up to 18.2 million shares upon conversion of a $10 million preferred equity interest at escalating prices ($0.55–$0.76), representing approximately 7% dilution at current prices with total potential dilution material to shareholders.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-08-25
EX-99.1
First Mining has entered into a Project Agreement with Slate Falls Nation governing development of the Springpole Gold Project, a major gold resource in northwestern Ontario. The agreement establishes collaborative frameworks for environmental management, employment, training, business opportunities, and financial benefit-sharing with the First Nation. This is a material operational and strategic milestone for advancing one of Canada's largest gold projects, following the federal Environmental Assessment approval in June 2026, and does not fit a discrete event category (not M&A, not a financing, not a governance change) but is clearly a significant operational/partnership development affecting the project's path to development.
View raw filing on EDGAR →
6-K
Bankruptcy Filing
confidence 95%
filed 2026-08-25
Braskem S.A. and five affiliated entities have filed an extrajudicial restructuring plan (Plano de Recuperação Extrajudicial) under Brazilian Bankruptcy Law (Lei nº 11.101/05) on August 24, 2026, following a preliminary injunction obtained on June 24, 2026, and concurrent Chapter 15 filings in the U.S. Bankruptcy Court for the Southern District of New York. The document explicitly references the filing of a restructuring request before the 2nd Bankruptcy Court of São Paulo and describes a significant liquidity crisis driven by prolonged petrochemical industry downcycle, oversupply, margin compression, and extraordinary obligations related to a geological event in Alagoas. This constitutes a formal bankruptcy/restructuring proceeding that materially threatens the registrant's continued existence.
View raw filing on EDGAR →
6-K
M&A activity
confidence 75%
filed 2026-08-25
Braskem has filed a request for extrajudicial reorganization (a form of debt restructuring under Brazilian law) on August 24, 2026, with secured participation of creditors representing 39.6% of subject claims. The filing suspends enforceability of obligations and contemplates material amendments to debt terms, potential equity capitalization, and possible shareholder liquidity support. While this is a restructuring rather than a traditional M&A transaction, it constitutes a material change in the capital structure and financial obligations that would significantly affect a reasonable investor's assessment of the company's financial condition and future viability.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-25
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligations (debt securities). Schedule A reports two specific debt issuances: a $10 million fixed-rate bond maturing 8/27/2029 (trade date 8/19/2026) and a $1 billion variable-rate discount note maturing 12/21/2026 (trade date 8/20/2026). This is a classic debt_issuance event under Item 2.03, representing new direct financial obligations of the Federal Home Loan Bank of San Francisco.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-25
The disclosure announces a 2-year time charter contract extension for the M/V Jonathan P at $26,000/day, expected to generate approximately $12.7 million EBITDA over the minimum contracted period and increase charter coverage through 2028. This is a material operational and commercial event for a shipping company—securing long-term vessel employment at profitable rates directly affects revenue and cash flow. While not a discrete M&A transaction, it is a significant commercial contract that a reasonable investor would consider material to assessing the company's operational performance and financial outlook.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-25
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Des Moines. Schedule A details multiple debt securities with trade dates in August 2026, including fixed-rate bonds and variable-rate floaters totaling billions in principal amount. This is a classic debt issuance disclosure under Item 2.03, and the Bank explicitly acknowledges that "consolidated obligations issuance is material to the Bank."
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-25
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Topeka. Schedule A details three specific debt issuances with trade dates in August 2026, totaling approximately $1.015 billion in principal ($250M, $750M, and $15M), with maturities ranging from December 2026 to August 2028. This is a classic debt_issuance event under Item 2.03, and the aggregate principal amount makes it material to investors assessing the registrant's capital structure and financial obligations.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-25
Item 2.03
The filing discloses the creation of multiple direct financial obligations through the issuance of Consolidated Bonds and Consolidated Discount Notes by the Federal Home Loan Bank of Cincinnati. Schedule A lists ten separate bond issuances with trade dates in August 2026, ranging from $6 million to $1 billion in principal amount, with maturities from 2027 to 2046. The filing explicitly states that "Consolidated Obligations issuance is material to the FHLB," and these debt securities represent the primary funding mechanism for the institution's operations.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-25
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Pittsburgh. Schedule A itemizes specific debt securities issued on trade dates in August 2026, including variable-rate floaters totaling $1.5 billion and fixed-rate bonds totaling approximately $40 million. This is a classic debt issuance under Item 2.03, and the registrant explicitly notes that "consolidated obligations issuance is material to the FHLBank."
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-25
Item 2.03
The filing discloses the creation of multiple direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Chicago. Schedule A details 12 separate debt issuances with trade dates of 8/19/2026 and 8/20/2026, with principal amounts ranging from $15 million to $900 million, totaling approximately $3.745 billion in new debt obligations. This is a classic debt_issuance event under Item 2.03, and the Bank explicitly acknowledges that "consolidated obligations issuance is material to the Bank."
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-25
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds by the Federal Home Loan Bank of Boston. Schedule A details three specific bond issuances with trade dates in August 2026, totaling $50 million in principal ($15M + $25M + $10M), with maturity dates ranging from 2028 to 2031 and fixed coupon rates of 4.45%-4.625%. This is a classic debt issuance under Item 2.03, creating new direct financial obligations for the Bank.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-25
Item 2.03
The filing discloses the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Atlanta totaling approximately $3.6 billion in principal across multiple trade dates in August 2026. Schedule A details specific debt securities with varying maturities, rates, and terms. The filing explicitly states that "consolidated obligations issuance is material to the Bank," and Item 2.03 is the standard disclosure vehicle for creation of direct financial obligations. This represents a material debt issuance event.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-25
Item 2.03
The filing discloses the Federal Home Loan Bank of Indianapolis becoming the primary obligor on consolidated obligation bonds with aggregate par amounts of $435 million across three separate bond issuances with maturities ranging from 2028 to 2031. This constitutes creation of direct financial obligations under Item 2.03, meeting the definition of debt issuance. The materiality is evident from the substantial principal amounts and multi-year maturities involved.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-25
Item 2.03
The filing discloses the creation of a direct financial obligation through the issuance of a consolidated obligation bond by the Federal Home Loan Bank of Dallas. Schedule A reports a $250 million variable-rate bond (CUSIP 3130BBXD2) with a trade date of 8/21/2026 and maturity of 11/25/2026, representing a new debt obligation. This is a classic debt issuance under Item 2.03, material to investors assessing the Bank's capital structure and funding activities.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-25
Item 5.02
The Board established FY 2027 performance measures and goals for the Enterprise Scorecard under the WPTIP and EAIP, approved LTIP performance measures for FY 2027–FY 2029, and modified existing incentive plan measures and goals across multiple performance cycles. These actions directly constitute compensatory arrangements for officers and executives, as they define the performance metrics and thresholds that determine incentive payouts under the company's executive compensation plans.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-25
Item 7.01
The disclosure announces two new build-to-suit development projects totaling $23 million in committed pipeline investment for Hobby Lobby and Academy Sports, with construction started in August 2026 and expected delivery in Q2 2027. This is a material operational/strategic business event involving property acquisitions and development activity central to BNL's REIT business model, but does not fit the specific categories of M&A activity (no acquisition of an existing company), debt issuance, or other named financial events. The event would affect a reasonable investor's assessment of the company's growth pipeline and capital deployment strategy.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-08-25
Item 8.01
This Item 8.01 disclosure centers on three routine but material financial matters: (1) determination of net asset value per share for Class E and Class FA shares as of July 31, 2026 ($25.09 and $24.51 respectively); (2) approval of new offering prices for Class A, T, and I shares based on NAV and adjusted for commissions and fees; and (3) declaration of monthly distributions of $0.166667 per share. While these are standard administrative disclosures for a closed-end fund, the NAV determination and offering price adjustments are material to investors evaluating share pricing and the distribution declaration is material to shareholders. No specific event type (earnings_release, dividend_distribution, etc.) fully captures the multi-faceted nature of this disclosure, making financial_other the most appropriate classification.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-25
Item 2.02
Electromed issued a press release announcing financial results for Q4 FY 2026 and full fiscal year 2026, reporting record revenues of $73.8 million (up 15.3%), record operating income of $13.9 million (up 43.7%), and net income of $11.3 million (up 50.3%).
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-08-25
Item 5.02
James L. Cunniff, President and Chief Executive Officer of Electromed, Inc., has notified the Company of his intention to retire effective on or about April 2, 2027, and is expected to resign from the Board upon retirement. The Board has engaged an executive search firm to identify a successor.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-08-25
Item 8.01
The Board formed two new committees (Clinical and Regulatory Affairs Committee and Stockholder Engagement Committee) and appointed specific directors to lead them. This is a governance restructuring that affects board oversight and stockholder relations. While not a traditional executive appointment or departure, the creation of new board committees with named leadership and the anticipated appointment of a new director pursuant to a Cooperation Agreement constitute material governance changes that would inform investors about the company's governance structure and strategic direction.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-25
Item 2.02
This is a clear earnings release for Q2 2026 filed under Item 2.02 (Results of Operations and Financial Condition). The press release discloses unaudited condensed consolidated financial results for the quarter ended June 30, 2026, including revenue of $6.7 million (118% YoY growth), gross margin expansion to 67%, and net loss of $22.8 million. The filing includes full financial statements and operational highlights, which is typical of a quarterly earnings announcement. This is QumulusAI's first quarterly report since its July 16, 2026 Nasdaq IPO, making it material to investors assessing the company's post-IPO performance.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 82%
filed 2026-08-25
Item 1.01
Marten Transport entered into a Second Amendment to its Credit Agreement on August 19, 2026, which extends the credit facility term to August 19, 2031, increases the letter-of-credit sublimit to $50 million, and updates SOFR margin terms. This material modification extends the company's financing capacity and materially modifies its direct financial obligations.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-25
The filing discloses adoption of the FY2027 Long Term Incentive Plan and FY2027 Short Term Incentive Plan, with specific equity and cash compensation awards to named executive officers (James Clark, James Galeese, Thomas Caneris) including RSUs, PSUs, and performance-based bonuses. Additionally, a $3,000,000 retention award of RSUs was granted to CEO James Clark, and his base salary was increased to $900,000 effective September 1, 2026. These are compensatory arrangements for directors and officers under Item 5.02(e).
View raw filing on EDGAR →
8-K
M&A activity
confidence 90%
filed 2026-08-25
Item 7.01
Par Pacific announced that Laramie Energy, in which it owns a 46% non-controlling interest, entered into a definitive agreement to sell substantially all of its oil and gas assets for $485 million in cash plus potential earn-out payments. Par Pacific expects to receive approximately $146 million of the transaction consideration and will exit its investment in Laramie Energy, representing a material disposition expected to close by end of 2026.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-08-25
Item 5.03
GlobalTech Corp effected a 1-for-3 reverse stock split on August 27, 2026, pursuant to an amendment to its Articles of Incorporation filed with Nevada on August 24, 2026. The reverse split, approved by stockholders on December 29, 2025, reduces outstanding shares from approximately 152 million to approximately 50 million and is intended to facilitate a potential Nasdaq uplisting by meeting minimum bid price and closing stock price requirements.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-08-25
Item 7.01
The disclosure centers on operational and strategic progress toward completing a planned acquisition of a 132-acre biomass power facility in East Texas, including engagement of MDM Group to market the site to data center operators and AI companies, engagement of a power-generation services provider for plant recommissioning, and status updates on acquisition financing and closing timeline. While acquisition-related, the filing emphasizes operational workstreams and commercialization efforts rather than announcing a completed or materially altered M&A transaction; the acquisition remains subject to financing and has not closed. This is best classified as operational_other—a material strategic business development and project advancement—rather than ma_activity, which typically signals entry into, completion, or material change to an M&A agreement.
View raw filing on EDGAR →